[ABCL] QoQ Quarter Result on 30-Jun-2021 [#Q2]

Stock
[ABCL] AbCellera Biologics Inc.
Announcement Date
13-Aug-2021
Financial Year
2021
Quarter
30-Jun-2021 [#Q2]
Profit Trend
QoQ- -101.98%
YoY- -134.66%
Quarter Report
ABCL's Result
ABCL's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Revenue 316,581 139,331 5,508 27,643 202,741 207,908 9,362 947.95%
PBT 230,809 84,710 -24,972 -2,073 161,487 155,915 -2,693 -
Tax 62,236 24,762 -3,592 250 44,266 39 0 -
NP 168,573 59,948 -21,380 -2,323 117,221 117,000 -2,693 -
Tax Rate -26.96% -29.23% - - -27.41% -0.02% - -
Total Cost 148,008 79,383 26,888 29,966 85,520 90,909 12,055 433.01%
Ratio Analysis
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
NP Margin 53.25 43.03 -388.16 -8.40 57.82 56.27 -28.77 -
Per Share
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
EPS 0.54 0.21 -0.08 -0.01 0.43 0.43 -0.01 -
EPS Diluted 0.54 0.21 -0.08 -0.01 0.37 0.37 -0.01 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.